Medpace Holdings, Inc.
MEDP
$419.75
$2.460.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 24.19% | 19.97% | 13.88% | 9.94% | 9.87% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.19% | 19.97% | 13.88% | 9.94% | 9.87% |
| Cost of Revenue | 9.32% | 7.34% | 5.69% | 4.62% | 4.52% |
| Gross Profit | 31.16% | 26.01% | 17.88% | 12.57% | 12.58% |
| SG&A Expenses | -3.31% | 9.64% | 11.74% | 17.56% | 15.89% |
| Depreciation & Amortization | -3.73% | -3.85% | -0.76% | 3.17% | 6.68% |
| Other Operating Expenses | 45.45% | 34.62% | 16.73% | 5.65% | 4.50% |
| Total Operating Expenses | 24.41% | 20.04% | 11.39% | 6.41% | 5.73% |
| Operating Income | 23.36% | 19.71% | 24.03% | 25.18% | 28.65% |
| Income Before Tax | 18.80% | 13.96% | 20.03% | 24.72% | 32.80% |
| Income Tax Expenses | 71.60% | 27.56% | 28.83% | 34.31% | 30.03% |
| Earnings from Continuing Operations | 10.57% | 11.56% | 18.42% | 23.11% | 33.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.57% | 11.56% | 18.42% | 23.11% | 33.24% |
| EBIT | 23.36% | 19.71% | 24.03% | 25.18% | 28.65% |
| EBITDA | 21.73% | 18.26% | 22.40% | 23.67% | 27.08% |
| EPS Basic | 20.21% | 19.85% | 23.90% | 25.28% | 32.78% |
| Normalized Basic EPS | 29.20% | 22.70% | 26.04% | 27.18% | 32.18% |
| EPS Diluted | 21.37% | 21.05% | 25.23% | 26.54% | 33.55% |
| Normalized Diluted EPS | 30.44% | 23.96% | 27.36% | 28.35% | 32.83% |
| Average Basic Shares Outstanding | -8.02% | -6.79% | -4.47% | -1.79% | 0.52% |
| Average Diluted Shares Outstanding | -8.93% | -7.75% | -5.45% | -2.64% | 0.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |